https://www.globenewswire.com/Tracker?data=DvVIVOONb4W_otqsGftjtAYdx481mXscX6E5Q2iD8NAgBhqbCz6H5M0BEcj0_8FRLWVo548yd2hpgLlZ0do3kRveJblDLrlBqhc7I6orCz8jqoap19QlVMQcMqoLbJ2j PfizerMediaRelations@pfizer.com

Investoranfragen

+1 (212) 733-4848

https://www.globenewswire.com/Tracker?data=teOUhkLfr5GMACKuI0ValOPeVclMZjEHW2_mNBxlab3YvE8DAQpaj8dYE-gqSNPWt9Q9oHONBUR5EQSs0sJYmQ== IR@Pfizer.com

Kontakte BioNTech:

Medienanfragen

Jasmina Alatovic

+49 (0)6131 9084 1513

https://www.globenewswire.com/Tracker?data=Obw_ES0IVszq4Ha8bsqEJTtT_tMqIgDyHNGenIZkeShBqLsCPJSw8-xZHxA1gNyQooynw7TvdiN5bWnyf0MdqR-Yb9r9aEyNl22yQ0RlbiQ= Media@biontech.de

Investoranfragen

Sylke Maas, Ph.D.

+49 (0)6131 9084 1074

https://www.globenewswire.com/Tracker?data=XOmiMTtTsyr62bjicb3AQVu7GNR_srWXDyxhyAgZRxibNrEKctCSegU83-EdppkpcRsoOH_LEJSKhbFuQiYVPYmwNf_Fdeg9YFi7bxsRBeg= Investors@biontech.de

(END) Dow Jones Newswires

October 21, 2021 06:45 ET (10:45 GMT)